Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 5Hemorrhage 5Hematologic Neoplasms 3Head and Neck Neoplasms 2Brain Neoplasms 2Bone Neoplasms 2Recurrence 1Prostatic Neoplasms 1Postoperative Complications 1Osteosarcoma 1Myofibroma 1Metrorrhagia 1Meningioma 1Melanoma 1Leiomyoma 1Glioma 1Breast Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 149Docetaxel 138Paclitaxel 127Trastuzumab 119Tamoxifen 110Capecitabine 104Letrozole 92Epirubicin 79Doxorubicin 70Anastrozole 70exemestane 67Fulvestrant 65Fluorouracil 61Radiotherapy 60pertuzumab 40Gemcitabine 39Carboplatin 38Vinorelbine 34Goserelin 34Bevacizumab 29Zoledronic Acid 28Methotrexate 28Chemotherapy, Adjuvant 28eribulin 27Lapatinib 25ribociclib 24palbociclib 24Drug Therapy 22130-nm albumin-bound paclitaxel 20pegfilgrastim 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Breast Neoplasms × Tranexamic Acid × Clear all
NCT04918589 2022-04-06

Tranexamic Acid for Alloplastic Breast Reconstruction

McMaster University

Phase 3 Unknown
106 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡